A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
To explore the role of peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated derangements in myocardial metabolism in the pathogenesis of diabetic cardiomyopathy, insulinopenic mice with PPARalpha deficiency (PPARalpha(-/-)) or cardiac-restricted overexpression [myosin heavy chain (MHC)-PPAR] were characterized. Whereas PPARalpha(-/-) mice were protected from the development of diabetes-induced cardiac hypertrophy, the combination of diabetes and the MHC-PPAR genotype resulted in a more severe cardiomyopathic phenotype than either did alone. Cardiomyopathy in diabetic MHC-PPAR mice was accompanied by myocardial long-chain triglyceride accumulation. The cardiomyopathic phenotype was exacerbated in MHC-PPAR mice fed a diet enriched in triglyceride containing long-chain fatty acid, an effect that was reversed by discontinuing the high-fat diet and absent in mice given a medium-chain triglyceride-enriched diet. Reactive oxygen intermediates were identified as candidate mediators of cardiomyopathic effects in MHC-PPAR mice. These results link dysregulation of the PPARalpha gene regulatory pathway to cardiac dysfunction in the diabetic and provide a rationale for serum lipid-lowering strategies in the treatment of diabetic cardiomyopathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metabolic derangements in the diabetic heart are consistent with chronic activation of PPARα/PGC-1α [89, 90]”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [89]
Citations
Cites
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,086
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Lipotoxic heart disease in obese rats: Implications for human obesity
Zhou, Y.-T., Grayburn, P., Karim, A., Shimabukuro, M., Higa, M., Baetens, D., Orci, L., & Unger, R. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1784 · Cited by 1,265
A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture
Pick, E., & Keisari, Y. (1980) · Journal of Immunological Methods · doi:10.1016/0022-1759(80)90340-3 · Cited by 1,217
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
Self-citationThe cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
Self-citationA novel mouse model of lipotoxic cardiomyopathy
Chiu, H.-C., Kovacs, A., Ford, D. A., Hsu, F.-F., Garcia, R., Herrero, P., Saffitz, J. E., & Schaffer, J. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10947 · Cited by 760
Stone, P. H., Muller, J. E., Hartwell, T., York, B. J., Rutherford, J. D., Parker, C. B., Turi, Z. G., Strauss, H. W., Willerson, J. T., Robertson, T., et al. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90053-3 · Cited by 516
Myocardial utilization of carbohydrate and lipids
Neely, J. R., Rovetto, M. J., & Oram, J. F. (1972) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(72)90029-1 · Cited by 511
Research works printed but not linked: 3
- D D Belke, T S Larsen, E M Gibbs, D L Severson Am J Physiol 279, E1104–E1113 (2000).
- D J Paulson, M F Crass Am J Physiol 242, 1084–1094 (1982).
- T A Nicholl, G D Lopaschuk, J H McNeill Am J Physiol 261, H1053–H1059 (1991).
Cited by
Items 101–200 of 549
Adaptation and maladaptation of the heart in obesity
Harmancey, R., Wilson, C. R., & Taegtmeyer, H. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.110031 · Cited by 121
Glycogen Synthase Kinase-3α Promotes Fatty Acid Uptake and Lipotoxic Cardiomyopathy
Nakamura, M., Liu, T., Husain, S., Zhai, P., Warren, J. S., Hsu, C., Matsuda, T., Phiel, C. J., Cox, J. E., Tian, B., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.005 · Cited by 121
New Molecular Insights of Insulin in Diabetic Cardiomyopathy
Westermeier, F., Riquelme, J. A., Pavez, M., Garrido, V., Díaz, A., Verdejo, H. E., Castro, P. F., García, L., & Lavandero, S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00125 · Cited by 111
Cardiac ketone body metabolism
Kadir, A. A., Clarke, K., & Evans, R. D. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165739 · Cited by 121
Park, S.-Y., Kim, H.-J., Wang, S., Higashimori, T., Dong, J., Kim, Y.-J., Cline, G., Li, H., Prentki, M., Shulman, G. I., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00251.2004 · Cited by 108
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy
Wang, L., Cai, Y., Jian, L., Cheung, C. W., Zhang, L., & Xia, Z. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01188-0 · Cited by 121
RXR: From Partnership to Leadership in Metabolic Regulations
Desvergne, B. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)75001-4 · Cited by 120
Fujioka, D., Kawabata, K.-I., Saito, Y., Kobayashi, T., Nakamura, T., Kodama, Y., Takano, H., Obata, J.-E., Kitta, Y., Umetani, K., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00987.2005 · Cited by 115
“Furthermore, AMPK activation is known to stimulate fatty acid oxidation, which may lead to inhibition of cardiomyocyte hypertrophy (1, 6, 14, 15, 22).”
BackgroundCardiac Hypertrophy: Mechanisms and Therapeutic Opportunities
Gupta, S., Das, B., & Sen, S. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1474 · Cited by 115
Food and Western Disease: Health and Nutrition from an Evolutionary Perspective
Lindeberg, S. (2009) · Wiley eBooks · doi:10.1002/9781444317176 · Cited by 116
Borradaile, N. M., & Schaffer, J. E. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0035-y · Cited by 114
Cheng, H., Jiang, X., & Han, X. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04342.x · Cited by 113
Self-citationMedium-chain fatty acids modulate myocardial function via a cardiac odorant receptor
Jovancevic, N., Dendorfer, A., Matzkies, M., Kovarova, M., Heckmann, J. C., Osterloh, M., Boehm, M., Weber, L., Nguemo, F., Semmler, J., et al. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0600-y · Cited by 112
Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes
Severson, D. L. (2004) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-065 · Cited by 111
Diet-induced Lethality Due to Deletion of the Hdac3 Gene in Heart and Skeletal Muscle
Sun, Z., Singh, N., Mullican, S. E., Everett, L. J., Li, L., Yuan, L., Liu, X., Epstein, J. A., & Lazar, M. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277707 · Cited by 104
PPARs and the kidney in metabolic syndrome
Ruan, X. Z., Zheng, F., & Guan, Y. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00152.2007 · Cited by 111
Brindley, D. N., Kok, B. P., Kienesberger, P. C., Lehner, R. S., & Dyck, J. R. B. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00509.2009 · Cited by 108
Farhangkhoee, H., Khan, Z. A., Kaur, H., Xin, X., Chen, S., & Chakrabarti, S. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.008 · Cited by 108
Lee, W.-S., & Kim, J. (2015) · PPAR Research · doi:10.1155/2015/271983 · Cited by 91
Leichman, J. G., Wilson, E. B., Scarborough, T., Aguilar, D., Miller, C. C., Yu, S., Algahim, M. F., Reyes, M., Moody, F. G., & Taegtmeyer, H. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.06.033 · Cited by 100
High fat diet induced diabetic cardiomyopathy
Dirkx, E., Schwenk, R. W., Glatz, J. F. C., Luiken, J. J. F. P., & van Eys, G. J. J. M. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.04.018 · Cited by 104
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
Athithan, L., Gulsin, G. S., McCann, G. P., & Levelt, E. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i10.490 · Cited by 102
Myocardial Rev-erb–Mediated Diurnal Metabolic Rhythm and Obesity Paradox
Song, S., Tien, C., Cui, H., Basil, P., Zhu, N., Gong, Y., Li, W., Li, H., Fan, Q., Choi, J. M., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.056076 · Cited by 102
Aubert, G., Vega, R. B., & Kelly, D. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.08.015 · Cited by 102
Self-citationApolipoprotein B Production Reduces Lipotoxic Cardiomyopathy
Yokoyama, M., Yagyu, H., Hu, Y., Seo, T., Hirata, K., Homma, S., & Goldberg, I. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311995200 · Cited by 94
Tan, X., Xie, G., Sun, X., Li, Q., Zhong, W., Qiao, P., Sun, X., Jia, W., & Zhou, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061409 · Cited by 92
The PPARα‐PGC‐1α Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium
Duncan, J. G., & Finck, B. N. (2007) · PPAR Research · doi:10.1155/2008/253817 · Cited by 101
Self-citationGolfman, L. S., Wilson, C. R., Sharma, S., Burgmaier, M., Young, M. E., Guthrie, P. H., Van Arsdall, M., Adrogue, J. V., Brown, K. K., & Taegtmeyer, H. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00055.2005 · Cited by 99
“High rates of fatty acid uptake in the diabetic myocardium result in the accumulation of myocardial lipid and lipid intermediates, mitochondrial/peroxisomal generation of reactive oxygen species, and excessive oxygen consumption (18, 50, 52).”
BackgroundCai, L. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.06.007 · Cited by 99
Wu, L., Wang, K., Wang, W., Wen, Z., Wang, P., Liu, L., & Wang, D. W. (2018) · Aging Cell · doi:10.1111/acel.12763 · Cited by 92
Insulin resistance protects the heart from fuel overload in dysregulated metabolic states
Taegtmeyer, H., Beauloye, C., Harmancey, R., & Hue, L. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00854.2012 · Cited by 95
Pulinilkunnil, T., Kienesberger, P. C., Nagendran, J., Waller, T. J., Young, M. E., Kershaw, E. E., Korbutt, G. S., Haemmerle, G., Zechner, R., & Dyck, J. R. B. (2013) · Diabetes · doi:10.2337/db12-0927 · Cited by 97
Diabetic cardiomyopathy: A metabolic perspective
Avogaro, A., de Kreutzenberg, S. V., Negut, C., Tiengo, A., & Scognamiglio, R. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.11.003 · Cited by 97
Mishra, R., Emancipator, S. N., Miller, C. M., Kern, T. S., & Simonson, M. S. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00323.2003 · Cited by 95
Irie, H., Krukenkamp, I. B., Brinkmann, J. F. F., Gaudette, G. R., Saltman, A. E., Jou, W., Glatz, J. F. C., Abumrad, N. A., & Ibrahimi, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1132094100 · Cited by 95
Metabolic remodeling in hypertrophied and failing myocardium: a review
Peterzan, M. A., Lygate, C. A., Neubauer, S., & Rider, O. J. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00731.2016 · Cited by 96
The Mitochondria in Diabetic Heart Failure: From Pathogenesis to Therapeutic Promise
Schilling, J. D. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6294 · Cited by 87
Reszko, A. E., Kasumov, T., David, F., Jobbins, K. A., Thomas, K. R., Hoppel, C. L., Brunengraber, H., & Des Rosiers, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400162200 · Cited by 82
Sphingolipids, Lipotoxic Cardiomyopathy, and Cardiac Failure
Park, T., & Goldberg, I. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.003 · Cited by 90
The Non-coding RNA gadd7 Is a Regulator of Lipid-induced Oxidative and Endoplasmic Reticulum Stress
Brookheart, R. T., Michel, C. I., Listenberger, L. L., Ory, D. S., & Schaffer, J. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806209200 · Cited by 83
Schrauwen-Hinderling, V. B., Hesselink, M. K. C., Meex, R., van der Made, S., Schär, M., Lamb, H., Wildberger, J. E., Glatz, J., Snoep, G., Kooi, M. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2076 · Cited by 82
Concurrent diabetes and heart failure: interplay and novel therapeutic approaches
Karwi, Q. G., Ho, K. L., Pherwani, S., Ketema, E. B., Sun, Q., & Lopaschuk, G. D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab120 · Cited by 90
Radionuclide Imaging of Myocardial Metabolism
Peterson, L. R., & Gropler, R. J. (2010) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.109.860593 · Cited by 89
Medium-chain Fatty Acids as Metabolic Therapy in Cardiac Disease
Labarthe, F., Gélinas, R., & Rosiers, C. D. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6084-0 · Cited by 88
Nediani, C., Raimondi, L., Borchi, E., & Cerbai, E. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3198 · Cited by 89
Morgan, E. E., Rennison, J. H., Young, M. E., McElfresh, T. A., Kung, T. A., Tserng, K.-Y., Hoit, B. D., Stanley, W. C., & Chandler, M. P. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01014.2005 · Cited by 86
Mansor, L. S., Fialho, M. D. L. S., Yea, G., Coumans, W. A., West, J. A., Kerr, M. J., Carr, C. A., Luiken, J. J. F. P., Glatz, J. F. C., Evans, R. D., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx045 · Cited by 86
Role of Differential Signaling Pathways and Oxidative Stress in Diabetic Cardiomyopathy
Watanabe, K., A. Thandavarayan, R., Harima, M., R. Sari, F., Gurusamy, N., T. Veeraveedu, P., Mito, S., Arozal, W., Sukumaran, V., Prasath Laksmanan, A., et al. (2010) · Current Cardiology Reviews · doi:10.2174/157340310793566145 · Cited by 77
Emerging role of epigenetics and miRNA in diabetic cardiomyopathy
Asrih, M., & Steffens, S. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.07.004 · Cited by 84
Panagia, M., Gibbons, G. F., Radda, G. K., & Clarke, K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00200.2004 · Cited by 84
Transcriptional Control of Cardiac Fuel Metabolism and Mitochondrial Function
Leone, T. C., & Kelly, D. P. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.011965 · Cited by 77
Self-citationLipids in the heart: a source of fuel and a source of toxins
Park, T., Yamashita, H., Blaner, W. S., & Goldberg, I. J. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32814a57db · Cited by 80
Myocardial substrate metabolism in obesity
Rider, O. J., Cox, P., Tyler, D. J., Clarke, K., & Neubauer, S. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.170 · Cited by 79
Contribution of Impaired Insulin Signaling to the Pathogenesis of Diabetic Cardiomyopathy
Zamora, M., & Villena, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112833 · Cited by 80
Updating Experimental Models of Diabetic Cardiomyopathy
Fuentes‐Antrás, J., Picatoste, B., Gómez‐Hernández, A., Egido, J., Tuñón, J., & Lorenzo, Ó. (2015) · Journal of Diabetes Research · doi:10.1155/2015/656795 · Cited by 76
Gerber, L. K., Aronow, B. J., & Matlib, M. A. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00246.2006 · Cited by 62
Cardiac nuclear receptors: architects of mitochondrial structure and function
Vega, R. B., & Kelly, D. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88888 · Cited by 76
Self-citationLipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy
Ritchie, R. H., Zerenturk, E. J., Prakoso, D., & Calkin, A. C. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0249 · Cited by 77
Rennison, J. H., McElfresh, T. A., Okere, I. C., Vazquez, E. J., Patel, H., Foster, A. B., Patel, K. K., Chen, Q., Hoit, B. D., Tserng, K., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01021.2006 · Cited by 75
Jiang, X., Goldberg, I. J., & Park, T. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_2 · Cited by 75
Huang, T. H.-W., Yang, Q., Harada, M., Uberai, J., Radford, J., Li, G. Q., Yamahara, J., Roufogalis, B. D., & Li, Y. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.07.020 · Cited by 74
Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy
SHARMA, N., Okere, I. C., Duda, M. K., Chess, D. J., O’Shea, K. M., & Stanley, W. C. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.007 · Cited by 76
Peroxisome proliferator activated
Alexander, S. P. H., Mathie, A. A., & Peters, J. A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706481 · Cited by 74
The role of miR-320 in glucose and lipid metabolism disorder-associated diseases
Du, H., Zhao, Y., Yin, Z., Wang, D. W., & Chen, C. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.53419 · Cited by 73
Manna, P., Ghosh, J., Das, J., & Sil, P. C. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.12.024 · Cited by 73
The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity
Karwi, Q. G., Sun, Q., & Lopaschuk, G. D. (2021) · Cells · doi:10.3390/cells10113259 · Cited by 72
Ueno, M., Suzuki, J., Zenimaru, Y., Takahashi, S., Koizumi, T., Noriki, S., Yamaguchi, O., Otsu, K., Shen, W., Kraemer, F. B., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00016.2008 · Cited by 74
Slater-Jefferies, J. L., Lillycrop, K. A., Townsend, P. A., Torrens, C., Hoile, S. P., Hanson, M. A., & Burdge, G. C. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000425 · Cited by 69
Ali, S., Ussher, J. R., Baggio, L. L., Kabir, M. G., Charron, M. J., Ilkayeva, O., Newgard, C. B., & Drucker, D. J. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2014.11.005 · Cited by 69
Djouadi, F., Lecarpentier, Y., Hebert, J.-L., Charron, P., Bastin, J., & Coirault, C. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp183 · Cited by 65
Pellieux, C., Montessuit, C., Papageorgiou, I., & Lerch, R. A. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp004 · Cited by 68
Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy
Lee, T.-I., Kao, Y., Chen, Y.-C., Huang, J.-H., Hsiao, F., & Chen, Y.-J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.01.008 · Cited by 68
Creus, A., Ferreira, M., Oliva, M., & Lombardo, Y. B. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020018 · Cited by 68
Li, X., Wu, Y., Zhao, J., Wang, H., Tan, J. H., Yang, M. W. O., Li, Y., Deng, S., Gao, S., Li, H., et al. (2020) · Theranostics · doi:10.7150/thno.40735 · Cited by 68
Beaudoin, M., Perry, C. G. R., Arkell, A. M., Chabowski, A., Simpson, J. A., Wright, D. C., & Holloway, G. P. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.270538 · Cited by 67
miR-21-5p regulates mitochondrial respiration and lipid content in H9C2 cells
Nasci, V. L., Chuppa, S. L., Griswold, L., Goodreau, K. L., Dash, R. K., & Kriegel, A. J. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00538.2017 · Cited by 67
Cho, Y.-R., Kim, H.-J., Park, S.-Y., Ko, H. J., Hong, E.-G., Higashimori, T., Zhang, Z., Jung, D. Y., Ola, M. S., LaNoue, K. F., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00376.2006 · Cited by 64
Cheng, H., Guan, S., & Han, X. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03794.x · Cited by 66
Self-citationHyyti, O. M., Ledee, D., Ning, X.-H., Ge, M., & Portman, M. A. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00931.2009 · Cited by 66
Azimzadeh, O., Sievert, W., Sarioglu, H., Yentrapalli, R., Barjaktarović, Ž., Sriharshan, A., Ueffing, M., Janik, D., Aichler, M., Atkinson, M. J., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr400071g · Cited by 65
Peroxisome proliferator-activated receptors: Bridging metabolic syndrome with molecular nutrition
Guri, A. J., Hontecillas, R., & Bassaganya-Riera, J. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.08.006 · Cited by 66
Mourmoura, E., Vial, G., Laillet, B., Rigaudière, J., Hininger‐Favier, I., Dubouchaud, H., Morio, B., & Demaison, L. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-49 · Cited by 64
Heart in Diabetes: Not Only a Macrovascular Disease
Stratmann, B., & Tschoepe, D. (2011) · Diabetes Care · doi:10.2337/dc11-s208 · Cited by 64
Davidoff, A. J., Mason, M. M., Davidson, M. B., Carmody, M. W., Hintz, K. K., Wold, L. E., Podolin, D. A., & Ren, J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00358.2003 · Cited by 60
KLF15 and PPARαCooperate to Regulate Cardiomyocyte Lipid Gene Expression and Oxidation
Prosdocimo, D. A., John, J. E., Zhang, L., Efraim, E. S., Zhang, R., Liao, X., & Jain, M. K. (2015) · PPAR Research · doi:10.1155/2015/201625 · Cited by 63
Vikramadithyan, R. K., Hirata, K., Yagyu, H., Hu, Y., Augustus, A. S., Homma, S., & Goldberg, I. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.080259 · Cited by 63
Cardiomyopathy in Type 2 Diabetes: Update on Pathophysiological Mechanisms
Saunders, J. A., Mathewkutty, S., Drazner, M. H., & McGuire, D. K. (2008) · Herz · doi:10.1007/s00059-008-3115-3 · Cited by 63
Cardioprotective role of sphingosine-1-phosphate.
Knapp, M. (2011) · PubMed · Cited by 62
Forcheron, F., Basset, A., Abdallah, P., del Carmine, P., Gadot, N., & Beylot, M. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-16 · Cited by 62
Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure
Rennison, J. H., McElfresh, T. A., Chen, X., Anand, V. R., Hoit, B. D., Hoppel, C. L., & Chandler, M. P. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.02.019 · Cited by 63
Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats
Dong, S., Hong, Y., Liu, M. R., Hao, Y., Yu, H.-S., Liu, Y., & Sun, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.024 · Cited by 61
Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload
Elezaby, A., Sverdlov, A. L., Tu, V. H., Soni, K., Luptak, I., Qin, F., Liesa, M., Shirihai, O. S., Rimer, J. M., Schaffer, J. E., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.12.001 · Cited by 63
Kuramoto, K., Sakai, F., Yoshinori, N., Nakamura, T. Y., Wakabayashi, S., Kojidani, T., Haraguchi, T., Hirose, F., & Osumi, T. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00133-14 · Cited by 61
Feng, W. H., Lei, T., Wang, Y., Feng, R. M., Yuan, J.-T., Shen, X., Wu, Y., Gao, J., Ding, W., & Lu, Z. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.445 · Cited by 60
Duda, M. K., O’Shea, K. M., Lei, B., Barrows, B. R., Azimzadeh, A. M., McElfresh, T. A., Hoit, B. D., Kop, W. J., & Stanley, W. C. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.11.003 · Cited by 60
Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice
How, O.-J., Larsen, T. S., Hafstad, A. D., Khalid, A. M., Myhre, E. S. P., Murray, A. J., Boardman, N. T., Cole, M. A., Clarke, K., Severson, D. L., et al. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701783281 · Cited by 60
Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets
Sung, M. M. Y., Hamza, S. M., & Dyck, J. R. B. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6305 · Cited by 59
The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathy
Ussher, J. R. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.891939 · Cited by 59
Duncan, J. G. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-9889-8 · Cited by 61
Fine-Mapping Gene-by-Diet Interactions on Chromosome 13 in a LG/J × SM/J Murine Model of Obesity
Ehrich, T. H., Hrbek, T., Kenney-Hunt, J. P., Pletscher, L. S., Wang, B., Semenkovich, C. F., & Cheverud, J. M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1863 · Cited by 51
Metadata
- Authors
- Finck, B. N., Han, X., Courtois, M., Aimond, F., Nerbonne, J. M., Kovacs, A., Gross, R. W., & Kelly, D. P.
- Affiliations
- Washington University in St. Louis (US)
- Departments of Medicine, Molecular Biology and Pharmacology, and Pediatrics, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, MO 63110
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-01-27
- Volume
- 100
- Issue
- 3
- Pages
- 1226-1231
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC298755
- OpenAlex
- W1968715224
- Cited by
- 501
- References
- 26
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 11 · 2021: 18 · 2020: 16 · 2019: 12 · 2018: 14 · 2017: 16 · 2016: 19 · 2015: 20 · 2014: 27 · 2013: 27 · 2012: 31
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK-52574, DK56341, HL57278)
- National Heart, Lung, and Blood Institute (P01HL57278, P01 HL 13851, P01HL057278, P01HL013851, F32HL067575)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK-52574, R01 DK45416, R01DK045416, P30-DK56341, P30DK056341, P30DK052574)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- diabetic cardiomyopathy, PPARα, lipotoxicity, dietary fat, medium-chain triglycerides, cardiac hypertrophy, reactive oxygen species, myocardial metabolism, lipid-lowering therapy
- MeSH terms
- Adenosine Triphosphate, Animals, Ceramides, Diabetes Mellitus, Experimental, Diabetic Angiopathies, Dietary Fats, Echocardiography, Electrophysiology, Glutathione, Hydrogen Peroxide, Cardiomyopathies, Myocardium, Phenotype, Time Factors, Transcription Factors, Triglycerides, Blotting, Northern, Receptors, Cytoplasmic and Nuclear, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.